Abstract 3761: HSK26784: An oral PROTAC-BTK degrader for multiple B lymphocyte derived malignancies

布鲁顿酪氨酸激酶 伊布替尼 酪氨酸激酶 癌症研究 断点群集区域 B细胞 B细胞受体 淋巴细胞 生物 慢性淋巴细胞白血病 药理学 信号转导 免疫学 细胞生物学 白血病 受体 生物化学 抗体
作者
Meilin Qian,Fei Ye,Chen Zhang,Jianming Wang,Yuanli Zhang,Yangyang Cui,Linli Li,Xiaoli Gou,Jia Ni
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:80 (16_Supplement): 3761-3761
标识
DOI:10.1158/1538-7445.am2020-3761
摘要

Abstract PROteolysis TArgeting Chimeras (PROTACs) have emerged as a new and promising modality utilizing an event-driven MOA, whereby protein levels could be modulated by PROTAC-induced degradation by hijacking the ubiquitin-proteasome system. Starting from 2001, many target proteins have been studied, such as BET and kinase families as well as nuclear receptors. Bruton's tyrosine kinase (BTK) is an essential component of BCR pathway, which plays an important role in development, activation, proliferation, and survival of B lymphocytes. Ibrutinib is an irreversible inhibitor of BTK, and shows promising activity against multiple B lymphocyte derived malignancies. However, there remains a big concern about the development of Ibrutinib induced resistance by BTK C481S mutant. In our study, HSK26784 was found as a novel orally available BTK-PROTAC molecule, which could selectively degrade the BTK proteins. HSK26784 selectively degraded BTK proteins in Mino cell lines, with a half degradation concentration (DC50) of 22.9 nM. HSK26784 also effectively induced BTK degradation in mouse spleen, with a DC50 of 3.8 mg/kg. In addition, HSK26784 significantly inhibit the expression of CD69 on human PBMC cells after ex vivo BCR stimulation. HSK26784 could inhibit cell proliferation in many malignant B cell lines. In Ibrutinib sensitive cell lines, the inhibitory activity of HSK26784 is similar to that of Ibrutinib. While in the Ibrutinib non-sensitive cell lines, HSK26784 was more potent than Ibrutinib. Importantly, in the xenograft models, HSK26784 could also inhibit the tumor growth in a dose dependent manner. And HSK26784 achieved much better therapeutic effects than Ibrutinib. HSK26784 could inhibit the kinase activity of BTK wt and BTK C481S mutant, with IC50 of 11 nM and 14 nM respectively. It indicated that the efficacy of HSK26784 in BTK wt and BTK C481S mutant was comparable. HSK26784 showed good orally bioavailability in different species. The oral bio availabilities in mice, rats and dogs were 15.4 %, 11.8 % and 12.8 % respectively. In conclusion, HSK26784 is a promising BTK PROTAC degrader with better efficacy than Ibrutinib in multiple B lymphocytes. Citation Format: Meilin Qian, Fei Ye, Chen Zhang, Jianming Wang, Yuanli Zhang, Yangyang Cui, Linli Li, Xiaoli Gou, Jia Ni. HSK26784: An oral PROTAC-BTK degrader for multiple B lymphocyte derived malignancies [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 3761.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐乐的应助被huahuahua采纳,获得10
刚刚
Maestro_S的应助被huahuahua采纳,获得10
刚刚
人族首领的应助被huahuahua采纳,获得30
1秒前
bkagyin的应助被huahuahua采纳,获得10
1秒前
1秒前
敏于行发布了新的文献求助30
2秒前
情怀的应助被一见喜采纳,获得10
2秒前
zhou国兵发布了新的文献求助10
2秒前
66发布了新的文献求助10
3秒前
激动的忆翠完成签到,获得积分10
4秒前
168698发布了新的文献求助10
6秒前
yechangzhou完成签到,获得积分10
6秒前
7秒前
科研dog完成签到,获得积分10
8秒前
乐观的名完成签到,获得积分10
9秒前
LSH发布了新的文献求助10
10秒前
汉堡包的应助被史文韬采纳,获得10
11秒前
传奇3的应助被史文韬采纳,获得10
11秒前
11秒前
打打的应助被史文韬采纳,获得10
11秒前
CipherSage的应助被史文韬采纳,获得10
11秒前
李爱国的应助被史文韬采纳,获得10
11秒前
田様的应助被史文韬采纳,获得10
12秒前
烟花的应助被史文韬采纳,获得10
12秒前
Akim的应助被一二三采纳,获得10
12秒前
13秒前
Jasper的应助被qianzhihe采纳,获得10
13秒前
zz完成签到,获得积分10
13秒前
13秒前
13秒前
念槿完成签到,获得积分10
14秒前
15秒前
15秒前
15秒前
16秒前
16秒前
16秒前
17秒前
绵绵发布了新的文献求助10
18秒前
冲冲冲冲冲关注了科研通微信公众号
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194415
求助须知:如何正确求助?哪些是违规求助? 9580155
关于积分的说明 21870088
捐赠科研通 7793967
什么是DOI,文献DOI怎么找? 3437647
关于科研通互助平台的介绍 2560986
邀请新用户注册赠送积分活动 2484376